Celeste Krewson, Assistant Editor

A recent investigation sheds light on patient preferences and concerns regarding external cephalic version versus cesarean section for managing fetal malpresentation, revealing gaps in counseling and the desire for more information.

Misunderstandings surrounding bacterial vaginosis can delay treatment, but advancements such as XACIATO offer effective solutions, emphasizing the importance of open communication and continued research for comprehensive women's health care.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

Enmetazobactam (Exblifep; Orchid Pharma) gains FDA approval for treating complicated urinary tract infections in adults after demonstrating superiority over piperacillin-tazobactam in clinical cure and microbiological eradication in a global phase 3 trial.

A recent investigation sheds light on the efficacy of hormone therapy in alleviating depressive symptoms associated with menopause, revealing potential benefits for women undergoing natural menopause.

Recent research suggests AI computer vision technology could bolster the accuracy of HIV self-testing, potentially advancing HIV service accessibility and acceptance to meet Sustainable Development Goals.

Recent research highlighted the significant correlation between adverse childhood experiences and heightened risks of preeclampsia and depression during pregnancy.

Following a landmark decision regarding the status of embryos, the University of Alabama at Birmingham has suspended in vitro fertilization services, sparking concerns over reproductive rights and health care access as experts grapple with the legal aftermath.

Recent research highlighted an association between the total dose of prescribed opioids during pregnancy and the heightened risk of spontaneous preterm birth, emphasizing the need for judicious opioid use in pain management for expectant mothers.

A recent study evaluated the safety and effectiveness of the Onclarity HPV assay in detecting high-grade cervical disease, presenting findings on its comparability to predicate assays and potential for cost-saving benefits in screening practices.

Discover how immediate postoperative symptom burden varies between open and minimally invasive hysterectomies under enhanced recovery after surgery protocols, shedding light on recovery disparities in gynecologic surgery.

A recent study revealed that physical activity confers greater reductions in all-cause and cardiovascular mortality risk among women compared to men, emphasizing the importance of closing the gender gap in exercise participation.

Discover key findings from a comprehensive study on in vitro fertilization outcomes among women with obesity, shedding light on the importance of equitable access to fertility treatment regardless of body mass index.

Recent research highlights the efficacy and safety of relugolix combination therapy in managing uterine fibroid-associated heavy menstrual bleeding specifically among Black women, demonstrating outcomes comparable to the broader population.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

The Centers for Disease Control and Prevention's latest report unveils a 222% rise in maternal syphilis cases per 100,000 live births from 2016 to 2022, with increases observed across racial, age, and perinatal care groups nationwide.

Explore how the latest research underscores the efficacy of the 2017 Querleu-Morrow classification in defining radical hysterectomy extent, shedding light on surgical terminologies for cervical cancer management.

A recent study demonstrated the superior efficacy of cefepime–taniborbactam over meropenem for managing complicated urinary tract infections, suggesting a promising treatment option amid rising antibiotic resistance challenges.

Recent research delves into the repercussions of gestational diabetes mellitus on both maternal and perinatal health, shedding light on its effects in both singleton and twin pregnancies.

Recent findings revealed the efficacy and safety of the 2-step Graded Oral Challenge method in assessing penicillin allergy risk, offering a promising approach for improved patient care and antibiotic stewardship in low-risk individuals.

Delve into the intricate correlation between human chorionic gonadotropin levels during pregnancy and various adverse outcomes, shedding light on its multifaceted role in maternal-fetal health.

Adolescent pregnancy and sexual health care utilization declined during the COVID-19 pandemic, indicating significant disruptions in reproductive health services for young females, as highlighted in a recent study published in Pediatrics.

A comprehensive investigation uncovers the pervasive presence of endocrine-disrupting chemicals in menstrual hygiene items, potentially impacting gynecological and reproductive health.

A novel ultrasound technique allows for early and accurate prediction of preterm birth risk, potentially revolutionizing prenatal care for first-time pregnant women.

Delve into the dialogue surrounding women's cardiovascular health with Natalie Bello, MD, MPH, FACC, as she sheds light on the significance of American Heart Month and the impact of pregnancy on cardiovascular risk factors.

Recent research suggests strict abortion laws may deter applicants to obstetrics and gynecology residency programs, with implications for medical education and workforce diversity.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

Recent research suggests that a deeper understanding of pregnancy correlates with a greater likelihood of opposing legislation limiting abortion access, shedding light on the role of education in shaping public opinion on reproductive rights.

A recent study revealed an 8.47-fold increased risk of suicide attempts among individuals with polycystic ovary syndrome, prompting the need for proactive mental health management in patients and improved tools for assessing health-related quality-of-life.

Nipocalimab, a monoclonal antibody targeting maternal alloantibodies, has received FDA Breakthrough Therapy Designation for treating severe hemolytic disease of the fetus and newborn.